Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Diamedica Therapeutics Inc
(NQ:
DMAC
)
3.170
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Diamedica Therapeutics Inc
< Previous
1
2
3
4
5
Next >
DiaMedica Therapeutics Appoints David Wambeke as Chief Business Officer
April 11, 2023
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2022 Financial Results
March 28, 2023
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics's Earnings Outlook
March 27, 2023
Via
Benzinga
DiaMedica Therapeutics to Report Fourth Quarter 2023 Financial Results and Provide a Business Update March 29, 2023
March 20, 2023
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics to Present at the Oppenheimer 33rd Annual Healthcare Conference
March 13, 2023
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics Announces the Appointment of Biopharma Veteran Tanya Lewis to Its Board of Directors
March 06, 2023
From
DiaMedica Therapeutics Inc.
Via
Business Wire
$1 Million Bet On OmniAb? Check Out These 3 Penny Stocks Insiders Are Buying
December 02, 2022
The Dow Jones closed lower by around 200 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...
Via
Benzinga
DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2022 Financial Results
November 09, 2022
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics to Attend the 13th Annual Craig-Hallum Alpha Select Conference November 17, 2022
November 07, 2022
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics to Present at Credit Suisse 31st Annual Healthcare Conference
October 31, 2022
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics Provides Update on ReMEDy2 Trial
October 26, 2022
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics Appoints Julie Daves as SVP, Clinical Development Operations
September 14, 2022
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Why Meta Platforms Shares Dipped Around 25%; Here Are 77 Biggest Movers From Yesterday
October 28, 2022
Gainers UserTesting, Inc. (NYSE: USER) shares jumped 91.7% to close at $7.40 after the company announced it will be acquired by Thoma Bravo and Sunstone Partners for $1.3 billion. The company also...
Via
Benzinga
Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday
October 07, 2022
Gainers Green Giant Inc. (NASDAQ: GGE) jumped 161.1% to close at $1.88 after dipping 29% on Wednesday.
Via
Benzinga
DiaMedica Therapeutics to Present at Lake Street’s 6th Annual Best Ideas Growth Conference
September 06, 2022
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Why Revelation Biosciences Shares Are Trading Higher By 29%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
October 06, 2022
Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 98% to $0.2777. Statera Biopharma was recently granted European patent number EP3206708 titled "Methods And Compositions For The Treatment Of...
Via
Benzinga
DiaMedica Therapeutics: Q2 Earnings Insights
August 10, 2022
DiaMedica Therapeutics (NASDAQ:DMAC) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:30 PM. Here's what investors need to know about the announcement.
Via
Benzinga
DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2022 Financial Results
August 10, 2022
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial
August 10, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
DiaMedica Therapeutics Earnings Preview
August 09, 2022
DiaMedica Therapeutics (NASDAQ:DMAC) is set to give its latest quarterly earnings report on Wednesday, 2022-08-10. Here's what investors need to know before the announcement.
Via
Benzinga
DiaMedica Therapeutics to Report Second Quarter 2022 Financial Results and Provide a Business Update August 11, 2022
August 04, 2022
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics to Participate in the BTIG Biotechnology Conference 2022
August 01, 2022
From
DiaMedica Therapeutics Inc.
Via
Business Wire
3 Penny Stocks Insiders Are Buying: DiaMedica Therapeutics, Troika Media And More
July 22, 2022
U.S. stock futures traded lower this morning on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...
Via
Benzinga
This Low-Float Stock Jumps Around 148%; Here's 64 Biggest Movers From Yesterday
July 08, 2022
Gainers United Maritime Corporation (NASDAQ: USEA) climbed 147.6% to close at $7.08 on Thursday on heavy momentum following the company's recent listing on the Nasdaq Capital Market.
Via
Benzinga
Nasdaq Surges 250 Points; Crude Oil Rises Sharply
July 07, 2022
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite jumping 250 points following the release of data on initial jobless claims.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
July 07, 2022
Thursday's session saw 49 companies set new 52-week lows.
Via
Benzinga
Dow Jumps More Than 200 Points; Samsung Sees This Much Surge In Quarterly Revenue
July 07, 2022
U.S. stocks traded higher midway through trading, with the Dow Jones jumping more than 200 points following the release of data on initial jobless claims.
Via
Benzinga
This EV Maker Stock Jumps More Than 9%, Here's 46 Stocks Moving In Thursday's Mid-Day Session
July 07, 2022
Gainers United Maritime Corporation (NASDAQ: USEA) jumped 180.4% to $8.02. The company’s stock jumped 190% on Wednesday after completing its spin-off from Seanergy Maritime Holdings Corp.
Via
Benzinga
Why U.S. Stocks Are Trading Higher After Rise In Jobless Claims
July 07, 2022
U.S. stocks traded higher this morning, following the release of data on initial jobless claims.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 7, 2022
July 07, 2022
Upgrades
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.